Both in Biotechnology
Krystal Biotech vs Immunovant
Over the past year KRYS returned +67.2% and IMVT returned +49.5%; their daily moves had a correlation of 0.32.
KRYS +67.2% IMVT +49.5%Growth of $1, one year, split-adjusted
| Metric | KRYS | IMVT |
|---|---|---|
| Price | $318.97 | $28.75 |
| Market cap | $9.44B | $5.94B |
| Today | −0.99% | +1.30% |
| 1 month | −6.7% | −16.8% |
| 6 months | +19.0% | −0.6% |
| Year to date | +29.4% | +13.1% |
| 1 year | +67.2% | +49.5% |
| Revenue growth (YoY) | +24.1% | — |
| Gross margin | 94.6% | — |
| Net margin | 45.9% | — |
| P/E (TTM) | 39.1× | — |
| Price / sales | 21.4× | — |
| Net cash | $845.6M | $797.8M |
| Dividend yield | — | — |
| Volatility (60d) | 38.2% | 36.5% |
| Short % of float | 15.2% | 20.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).